Skip to main content
SpringerLink
Log in

Acute Stroke Emergency Management

  • Chapter
  • First Online:
Book cover Evidence-Based Critical Care

  • 91k Accesses

Abstract

Acute ischemic stroke management has changed greatly over the last few decades. Advancements in Computed Tomography, Magnetic Resonance Imaging and Digital Subtraction Angiography have carved a pathway in the diagnosis of stroke, which led to the acceleration of therapy. In the 1990s, therapeutic options for acute ischemic stroke were revolutionized with the administration of intravenous tissue plasminogen activator. In 2015, a series of endovascular trials further transformed the therapy for stroke patients. The following case report and chapter focuses on the diagnosis and management of acute ischemic stroke.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Jauch EC, Saver JL, Adams HP, et al. Guidelines for the early management of patients with acute ischemic stroke. Stroke. 2013;44:870–947.

    Article  PubMed  Google Scholar 

  2. Fonarow GC, Zhao X, et al. Door-to-needle times for tissue plasminogen activator administration and clinical outcomes in acute ischemic stroke before and after a quality improvement initiative. JAMA. 2014;311(16):1632–40.

    Article  PubMed  Google Scholar 

  3. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581–7.

    Article  Google Scholar 

  4. Hacke W, Kaste M, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke (ECASS III). N Engl J Med. 2008;359:1317–29.

    Article  CAS  PubMed  Google Scholar 

  5. Furlan AJ, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. JAMA. 1999;282:2003–11.

    Article  CAS  PubMed  Google Scholar 

  6. Powers WJ, et al. 2015 American Heart Association/American Stroke Association Focused Update of the 2013 Guidelines for the Early Management of Patients with Acute Ischemic Stroke Regarding Endovascular Treatment: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2015;46(10):3020–35.

    Article  CAS  PubMed  Google Scholar 

  7. Addition of stent thrombectomy in treatment of acute ischemic stroke patients reduces disability in global studies [Internet] 2015. [Accessed 2 Mar 2016]. Available from http://www.businesswire.com/news/home/20150211006099/en/Addition-Stent-Thrombectomy-Treatment-Acute-Ischemic-Stroke.

  8. Berkhemer OA, Fransen PS, Beumer D, et al. A randomized trial of intraarterial treatment for acute ischemic stroke (MR CLEAN). N Engl J Med. 2015;372(1):11–20.

    Article  PubMed  Google Scholar 

  9. Goyal M, Demchuk AM, Menon BK, et al. Randomized assessment of rapid endovascular treatment of ischemic stroke (ESCAPE). N Engl J Med. 2015;372(11):1019–30.

    Article  CAS  PubMed  Google Scholar 

  10. Campbell BC, Mitchell PJ, Kleinig TJ, et al. Endovascular therapy for ischemic stroke with perfusion-imaging selection (EXTEND IA). N Engl J Med. 2015;372(11):1009–18.

    Article  CAS  PubMed  Google Scholar 

  11. Saver JL, Goyal M, Bonafe A, et al. Solitaire™ with the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke (SWIFT PRIME) trial: protocol for a randomized, controlled, multicenter study comparing the Solitaire revascularization device with IV tPA with IV tPA alone in acute ischemic stroke. Int J Stroke. 2015;10(3):439–48.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Jovin TG, Chamorro A, Cobo E, et al. Thrombectomy within 8 hours after symptom onset in ischemic stroke (REVASCAT). N Engl J Med. 2015;372(24):2296–306.

    Article  CAS  PubMed  Google Scholar 

  13. Broderick JP, Berkhemer OA, Palesch YY, et al. Endovascular therapy is effective and safe for patients with severe ischemic stroke: pooled analysis of interventional management of stroke III and multicenter randomized clinical trial of endovascular therapy for acute ischemic stroke in the Netherlands data. IMS III investigators; MR CLEAN Investigators. Stroke. 2015;46(12):3416–22.

    Google Scholar 

  14. Faculty of Medicine, University of Calgary. Understanding Alberta Stroke Program Early CT score (ASPECTS) [Internet] 2015 [Accessed 2 Mar 2016]. Available from: http://www.aspectsinstroke.com/aspects/what-is-aspects.

  15. Hill MD, Demchuk AM, Goyal M. Alberta Stroke Program early computed tomography score to select patients for endovascular treatment: Interventional Management of Stroke (IMS)-III Trial. Stroke. 2014;45(2):444–9.

    Article  PubMed  Google Scholar 

  16. Hofmeijer J, Kappelle LJ, Algra A, Amelink GJ, van Gijn J, van der Worp HB, HAMLET investigators. Surgical decompression for space-occupying cerebral infarction (the Hemicraniectomy After Middle Cerebral Artery infarction with Life-threatening Edema Trial [HAMLET]): a multicentre, open, randomised trial. Lancet Neurol. 2009;8(4):326–33.

    Article  PubMed  Google Scholar 

  17. Jüttler E, Schwab S, Schmiedek P, Unterberg A, Hennerici M, Woitzik J, Witte S, Jenetzky E, Hacke W, DESTINY Study Group. Decompressive Surgery for the Treatment of Malignant Infarction of the Middle Cerebral Artery (DESTINY): a randomized, controlled trial. Stroke. 2007;38(9):2518–25.

    Article  PubMed  Google Scholar 

  18. Vahedi K, Vicaut E, Mateo J, Kurtz A, Orabi M, Guichard JP, Boutron C, Couvreur G, Rouanet F, Touzé E, Guillon B, Carpentier A, Yelnik A, George B, Payen D, Bousser MG, DECIMAL Investigators. Sequential-design, multicenter, randomized, controlled trial of early decompressive craniectomy in malignant middle cerebral artery infarction (DECIMAL Trial). Stroke. 2007;38(9):2506–17.

    Article  PubMed  Google Scholar 

  19. Sheth KN, Elm JJ, Beslow LA, et al. Glyburide Advantage in Malignant Edema and Stroke (GAMES-RP) Trial: rationale and design. Neurocrit Care. 2016;24:132–9.

    Article  CAS  PubMed  Google Scholar 

  20. Paciaroni M, Agnelli G, Falocci N, et al. Prognostic value of trans-thoracic echocardiography in patients with acute stroke and atrial fibrillation: findings from the RAF study. J Neurol. 2016;263:231–7.

    Article  PubMed  Google Scholar 

  21. Mozaffarian D,Benjamin EJ, Go AS, et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics – 2015 update: a report from the American Heart Association. Circulation. 2015;131(4):e29–e322.

    Google Scholar 

  22. EAFT (European Atrial Fibrillation Trial) Study Group. Secondary prevention in non-rheumatic atrial brillation after transient ischaemic attack or minor stroke. Lancet. 1993;342(8882):1255–62.

    Google Scholar 

  23. Lip GY, Nieuwlaat R, Pisters R, et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest. 2010;137(2):263–72.

    Article  PubMed  Google Scholar 

  24. Connolly SJ, Ezekowitz MD, Yusuf S, et al; RE-LY Steering Committee and Investigators. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009;361(12):1139–51.

    Google Scholar 

  25. Granger CB, Alexander JH, McMurray JJ, et al; ARISTOTLE Commit- tees and Investigators. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011;365(11):981–92.

    Google Scholar 

  26. Patel MR, Mahaffey KW, Garg J, et al; ROCKET AF Investigators. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011;365(10):883–91.

    Google Scholar 

  27. Giugliano RP, Ruff CT, Braunwald E, et al; ENGAGE AF-TIMI 48 Investigators. Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2013;369(22):2093–104.

    Google Scholar 

  28. Homma S, Thompson JL, Pullicino PM, et al. Warfarin and aspirin in patients with heart failure and sinus rhythm (WARCEF). N Engl J Med. 2012;366(20):1859–69.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Pullicino PM, Qian M, Sacco RL, et al. Recurrent stroke in the warfarin versus aspirin in reduced cardiac ejection fraction (WARCEF) trial. Cerebrovasc Dis. 2014;38(3):176–81.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Amarenco P, Bogousslavsky J, Callahan A 3rd, et al; Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med. 2006;355(6):549–59.

    Google Scholar 

  31. Amarenco P, Benavente O, Goldstein LB, et al; Stroke Prevention by Aggressive Reduction in Cholesterol Levels Investiga- tors. Results of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial by stroke subtypes. Stroke. 2009;40(4):1405–9.

    Google Scholar 

  32. Ridker PM, Danielson E, Fonseca FAH, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein (JUPITER). N Engl J Med. 2008;359:2195–207.

    Article  CAS  PubMed  Google Scholar 

  33. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet. 2001;358(9287):1033–41.

    Article  Google Scholar 

  34. Arauz-Pacheco C, Parrott MA, Raskin P, American Diabetes Association. Treatment of hypertension in adults with diabetes. Diabetes Care. 2003;26 Suppl 1:S80–2.

    PubMed  Google Scholar 

  35. Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009;338:b1665.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359(15):1577–89.

    Article  CAS  PubMed  Google Scholar 

  37. Ray KK, Seshasai SR, Wijesuriya S, et al. Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials. Lancet. 2009;373(9677):1765–72.

    Article  CAS  PubMed  Google Scholar 

  38. CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. CAST (Chinese Acute Stroke Trial) Collaborative Group. Lancet. 1997;349(9066):1641–9.

    Google Scholar 

  39. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group. Lancet. 1997;349(9065):1569–81.

    Google Scholar 

  40. Rimmele DL, Thomalla G. Wake-up stroke: clinical characteristics, imaging findings, and treatment option – an update. Front Neurol. 2014;5:35.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Markus HS, Hayter E, Levi C, et al. Antiplatelet treatment compared with anticoagulation treatment for cervical artery dissection (CADISS): a randomised trial. Lancet Neurol. 2015;14(4):361–7.

    Article  CAS  PubMed  Google Scholar 

  42. He J, Zhang Y, Xu T, et al. Effects of immediate blood pressure reduction on death and major disability in patients with acute ischemic stroke: the CATIS randomized clinical trial. JAMA. 2014;311(5):479–89.

    Article  CAS  PubMed  Google Scholar 

  43. Jüttler E, Unterberg A, Woitzik J, et al. DESTINY II Investigators. Hemicraniectomy in older patients with extensive middle-cerebral-artery stroke. N Engl J Med. 2014;370(12):1091–100.

    Google Scholar 

  44. Bernhardt J, Langhorne P, Lindley RI, et al. Efficacy and safety of very early mobilisation within 24 h of stroke onset (AVERT): a randomised controlled trial. Lancet. 2015;386(9988):46–55.

    Article  Google Scholar 

  45. Chollet F, Tardy J, Albucher JF, et al. Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial. Lancet Neurol. 2011;10(2):123–30.

    Article  CAS  PubMed  Google Scholar 

  46. Baird TA, Muir KW, Bone I. Basilar artery occlusion. Neurocrit Care. 2004;1:319–29.

    Article  PubMed  Google Scholar 

  47. Schonewille WJ, Wijman CA, Michel P, et al. The basilar artery international cooperation study (BASICS). Int J Stroke. 2007;2(3):220–3.

    Article  PubMed  Google Scholar 

  48. The IST-3 Collaborative Group. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 hours of acute ischemic stroke (the third international stroke trial IST-3): a randomized controlled trial. Lancet. 2012;379(9834): 2352–63.

    Google Scholar 

  49. Derdeyn CP, Chimowitz MI, Lynn MJ, et al; Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis Trial Investigators. Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the Final results of a randomised trial. Lancet. 2014;383(9914):333–41.

    Google Scholar 

  50. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis (NASCET). N Engl J Med. 1991;325(7):445–53.

    Google Scholar 

  51. Ferguson GG, Eliasziw M, Barr HW, et al. The North American Symptomatic Carotid Endarterectomy Trial: surgical results in 1415 patients. (NASCET). Stroke. 1999;30(9):1751–8.

    Article  CAS  PubMed  Google Scholar 

  52. International Carotid Stenting Study Investigators, Ederle J, Dobson J, et al. Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (International Carotid Stenting Study): an interim analysis of a randomised controlled trial. Lancet. 2010;375(9719):985–97.

    Article  PubMed Central  Google Scholar 

  53. Mantese VA, Timaran CH, Chiu D, et al. The Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST). Stroke. 2010;41:S31–4.

    Article  PubMed  PubMed Central  Google Scholar 

  54. Brott TG. Carotid revascularization and medical management for asymptomatic carotid stenosis trial (CREST-2). In: ClinicalTrials.gov [website on the Internet]. Bethseda: US National Library of Medicine; 2014.

    Google Scholar 

  55. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet. 1996;348(9038):1329–39.

    Google Scholar 

  56. Markus HS, Droste DW, Kaps M, et al. Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using doppler embolic signal detection: the Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) trial. Circulation. 2005;111(17):2233–40.

    Article  CAS  PubMed  Google Scholar 

  57. Wong KS, Chen C, Fu J, et al. Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): a randomised, open-label, blinded-endpoint trial. Lancet Neurol. 2010;9(5):489–97.

    Article  CAS  PubMed  Google Scholar 

  58. Diener HC, Bogousslavsky J, Brass LM, et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet. 2004;364(9431):331–7.

    Article  CAS  PubMed  Google Scholar 

  59. Bhatt DL, Fox KAA, Hacke W, et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events (CHARISMA). N Engl J Med. 2006;354:1706–17.

    Google Scholar 

  60. SPS3 Investigators, Benavente OR, Hart RG, et al. Effects of clopidogrel added to aspirin in patients with recent lacunar stroke. N Engl J Med. 2012;367(9):817–25.

    Google Scholar 

  61. Lee M, Saver JL, Hong KS, et al. Risk-benefit profile of long-term dual- versus single-antiplatelet therapy among patients with ischemic stroke: a systematic review and meta-analysis. Ann Intern Med. 2013;159(7):463.

    Article  PubMed  Google Scholar 

  62. Wang Y, Wang Y, Zhao X, et al; CHANCE Investigators. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med. 2013;369(1):11–9.

    Google Scholar 

  63. Johnston SC, Easton JD, Farrant M, et al. Platelet-oriented inhibition in new TIA and minor ischemic stroke (POINT) trial: rationale and design. Int J Stroke. 2013;8(6):479–83.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Neurocritical Care, Anesthesia Critical Care Medicine, The Johns Hopkins Hospital, Phipps 455, 1800 Orleans Street, Baltimore, 21287, MD, USA

    Pravin George & Lucia Rivera Lara

  2. Neurocritical Care, The Cleveland Clinic, Cerebrovascular Center, Mailcode S-80, 9500 Euclid Avenue, Cleveland, 44195, OH, USA

    Pravin George

Authors
  1. Pravin George
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lucia Rivera Lara
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Pravin George .

Editor information

Editors and Affiliations

  1. Division of Pulmonary and Critical Care, University of Michigan, Ann Arbor, Michigan, USA

    Robert C. Hyzy

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

George, P., Lara, L.R. (2017). Acute Stroke Emergency Management. In: Hyzy, R. (eds) Evidence-Based Critical Care. Springer, Cham. https://doi.org/10.1007/978-3-319-43341-7_35

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-43341-7_35

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-43339-4

  • Online ISBN: 978-3-319-43341-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation